Anticonvulsants and anxiolytics: Benzodiazepines

Anticonvulsants and anxiolytics: Benzodiazepines

Neurology

Neurology

Nervous system anatomy and physiology
Central nervous system histology
Peripheral nervous system histology
Neuron action potential
Sympathetic nervous system
Parasympathetic nervous system
Adrenergic receptors
Cholinergic receptors
Cranial nerves
Brachial plexus
Motor cortex
Muscle spindles and golgi tendon organs
Pyramidal and extrapyramidal tracts
Cerebellum
Basal ganglia: Direct and indirect pathway of movement
Spinal cord reflexes
Sensory receptor function
Somatosensory pathways
Somatosensory receptors
Photoreception
Optic pathways and visual fields
Auditory transduction and pathways
Vestibular transduction
Vestibulo-ocular reflex and nystagmus
Olfactory transduction and pathways
Taste and the tongue
Movement disorders: Pathology review
Hypokinetic movement disorders: Clinical
Parkinson disease
Essential tremor
Dementia with Lewy bodies
Anti-parkinson medications
Hyperkinetic movement disorders: Clinical
Huntington disease
Medications for neurodegenerative diseases
Tourette syndrome
Torticollis
Typical antipsychotics
Neuroleptic malignant syndrome
Serotonin syndrome
Neuromuscular junction and motor unit
Neuromuscular junction disorders: Pathology review
Myasthenia gravis
Lambert-Eaton myasthenic syndrome
Myalgias and myositis: Pathology review
Dermatomyositis
Polymyositis
Muscle weakness: Clinical
Amyotrophic lateral sclerosis
Spinal muscular atrophy
Syncope: Clinical
Dizziness and vertigo: Clinical
Vertigo: Pathology review
Anatomy and physiology of the ear
Vertigo
Meniere disease
Labyrinthitis
Acoustic neuroma (schwannoma)
Sciatica
Carpal tunnel syndrome
Winged scapula
Ulnar claw
Erb-Duchenne palsy
Thoracic outlet syndrome
Klumpke paralysis
Demyelinating disorders: Pathology review
Multiple sclerosis
Transverse myelitis
Central pontine myelinolysis
Acute disseminated encephalomyelitis
Guillain-Barre syndrome
Charcot-Marie-Tooth disease
Spinal cord disorders: Pathology review
Lower back pain: Clinical
Back pain: Pathology review
Cauda equina syndrome
Brown-Sequard Syndrome
Neurogenic bladder
Spinal disc herniation
Degenerative disc disease
Spinal stenosis
Seizures: Clinical
Seizures: Pathology review
Seizures and epilepsy
Febrile seizure
Early infantile epileptic encephalopathy (NORD)
Anticonvulsants and anxiolytics: Benzodiazepines
Anticonvulsants and anxiolytics: Barbiturates
Nonbenzodiazepine anticonvulsants
Muscle weakness: Clinical
Stroke: Clinical
Cerebral vascular disease: Pathology review
Ischemic stroke
Transient ischemic attack
Intracerebral hemorrhage
Epidural hematoma
Subdural hematoma
Subarachnoid hemorrhage
Saccular aneurysm
Arteriovenous malformation
Broca aphasia
Wernicke aphasia
Wernicke-Korsakoff syndrome
Kluver-Bucy syndrome
Headaches: Clinical
Headaches: Pathology review
Migraine
Migraine medications
Tension headache
Cluster headache
Trigeminal neuralgia
Bell palsy
Cavernous sinus thrombosis
Disorders of consciousness: Clinical
Idiopathic intracranial hypertension
Normal pressure hydrocephalus
Brain herniation
Traumatic brain injury: Clinical
Traumatic brain injury: Pathology review
Concussion and traumatic brain injury
Shaken baby syndrome
Brain tumors: Clinical
Adult brain tumors: Pathology review
Pediatric brain tumors: Pathology review
Neurocutaneous disorders: Pathology review
Congenital neurological disorders: Pathology review
Spina bifida
Chiari malformation
Dandy-Walker malformation
Tethered spinal cord syndrome
Aqueductal stenosis
Septo-optic dysplasia
Cerebral palsy
Spinocerebellar ataxia (NORD)

Transcript

Watch video only

Benzodiazepines are a class of medications that act as a central nervous system depressant.  They have a wide variety of uses including anxiolytic effects, or to relieve anxiety; as anticonvulsants, or to manage seizure disorders; as a hypnotic for insomnia; as an anesthetic; and to treat withdrawal syndromes. They act by enhancing the main inhibitory neurotransmitter gamma-aminobutyric acid, or GABA, by binding to its receptor.  

It’s pretty well-established that your brain’s really important. It controls your feelings, your movements, your sleep, your memory… It controls everything, whether you’re aware of it or not. The cells that make up our brain are called neurons. Neurons communicate with each other through neurotransmitters. When one neuron is stimulated, it’ll release excitatory neurotransmitters like glutamate which bind to receptors on the next neuron. This causes the next neuron to depolarize and release its own excitatory neurotransmitters, propagating the signal throughout the brain.  

Now, we also have inhibitory neurons that will shut down this chain of events. These neurons release the main inhibitory neurotransmitter gamma-aminobutyric acid, or GABA, which binds to GABA receptors on other neurons. These receptors are large, multi unit complexes that form ligand-gated ion channels that open up to let Cl- ions into the cell. The influx of negatively charged ions causes hyperpolarization, where the cell’s membrane potential becomes more negative, which means it’s much more difficult for it to depolarize and fire off an action potential, meaning it’s less responsive to stimuli.  

Alright, now there are cases where neurons in the brain start sending out more excitatory signals than normal. This can occur due to either too much excitation by the excitatory neurotransmitters, or too little inhibition by the inhibitory neurotransmitters like GABA. Excessive excitatory signals can cause psychiatric disorders like anxiety, and neurological disorders like seizures and epilepsy.  

Okay, so one way we can decrease the excitatory signals is by enhancing the effect of inhibitory neurons through medication like benzodiazepines. They are composed of a benzene ring that consists of six carbon atoms fused to a diazepine ring that is made up of 5 carbon atoms and two nitrogen atoms.    
Now, based on the overall duration of action, these medications can be subdivided into short-acting benzodiazepines, like ALPRAZolam, Triazolam, Oxazepam, and Midazolam; intermediate-acting benzodiazepines, such as Temazepam, LORazepam, and ClonazePAM; and finally, long-acting benzodiazepines, like ChlordiazePOXIDE, DiazePAM, and Flurazepam. So, to remember short-acting benzodiazepines think of “ATOM”; for intermediate-acting, remember that these medications are tender, loving, and caring, or short TLC; and finally for long-acting benzodiazepines, think of alphabet and it’s order CDeF. These medications target the BZ site of GABAA receptors, which is located between ⍺1 and 2 subunits of the receptor. When both benzodiazepine and GABA bind to their separate sites on the receptor, benzodiazepines increase the frequency of Cl- channels opening, thereby increasing the influx of Cl- ions. As a result, high intracellular concentrations of Cl- ions cause membrane hyperpolarization, which means it’s much more difficult for neuron to depolarize and fire off an action potential. Now, a similar group of medications called barbiturates also function by binding to GABAA receptors. The important distinction is that barbiturates work by increasing the duration of Cl- channels opening and unlike benzodiazepines, they can cause the channels to open even in the absence of GABA.

Now, let’s draw a chart of the dose-dependent effects of benzodiazepines. On the left side of the chart, let’s place central nervous effects and on the bottom, let’s place dose. Low doses of benzodiazepines cause sedation, disinhibition, and anxiolysis; but as the dose increases, benzodiazepines cause hypnosis and anesthesia. Since they don’t have GABA mimetic effect, benzodiazepines reach the plateau; therefore they are not associated with medullary depression and coma.  

Alright, so benzodiazepines are indicated when the neurons get “super excited” and we want to calm them down like in anxiety disorders, or during a panic attack. It’s important to note that preferred medications for the long-term treatment of panic attacks are selective serotonin reuptake inhibitors, or short SSRIs, due to abuse potential, dependence, and tolerance of benzodiazepines. Benzodiazepines are also very effective anticonvulsants and are considered the treatment of choice for status epilepticus, which is when a person has over 5 minutes of ongoing seizures or multiple seizures without returning to normal in between. Certain benzodiazepines are also used for anesthesia since we basically want to depress the function of the patient’s nervous system. For the same reason, they are an effective treatment for insomnia, but they decrease REM sleep. Moreover, because they decrease REM sleep, they can also be used to treat night terrors, which is a sleep disorder similar to nightmares but far more dramatic as it’s associated with screaming and crying. Since alcohol and barbiturates also work by targeting GABAA receptors, benzodiazepines can be used to manage their withdrawal symptoms by decreasing their severity. DiazePAM can also be used as the second-line treatment for eclampsia, which is a life-threatening complication of pregnancy that is associated with seizures. But, it’s important to note that diazePAM should be used only if seizures recur after giving magnesium sulfate (MgSO4), which is the first-line treatment for eclampsia. Finally, they are sometimes used as muscle relaxants to treat spasms, like those caused by cerebral palsy

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Long-, intermediate- and short-acting benzodiazepine effects on human sleep EEG spectra" Psychiatry and Clinical Neurosciences (2003)
  5. "Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam" Clin Pharmacol Ther (1986)
  6. "Short acting benzodiazepines" BMJ (1993)
  7. "Treatment of Benzodiazepine Dependence" N Engl J Med (2017)